HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dongxia Feng Selected Research

Dongxia Feng Research Topics

Disease

5Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
09/2017 - 07/2013
3Brain Injuries (Brain Injury)
09/2017 - 01/2017
2Cerebrospinal Fluid Leak
02/2023 - 06/2022
2COVID-19
10/2020 - 01/2020
2Stroke (Strokes)
02/2018 - 09/2017
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2018 - 01/2017
2Ischemic Stroke
01/2017 - 08/2014
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2014 - 08/2014
1Fistula
09/2023
1Hematoma
09/2023
1Neurologic Manifestations (Neurological Manifestations)
09/2023
1Infections
06/2022
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
11/2021
1Infarction (Infarctions)
02/2018
1Anterior Cerebral Artery Infarction (Anterior Cerebral Artery Syndrome)
02/2018
1Cognitive Dysfunction
01/2018
1Central Nervous System Diseases (CNS Diseases)
01/2017
1Edema (Dropsy)
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Brain Death (Brain Dead)
01/2017
1Ischemia
08/2014
1Brain Ischemia (Cerebral Ischemia)
08/2014
1Diffuse Axonal Injury
05/2000

Drug/Important Bio-Agent (IBA)

1CytokinesIBA
09/2017
1HMGB1 Protein (HMG1)IBA
09/2017
1NADPH Oxidases (NAD(P)H oxidase)IBA
03/2017
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
01/2017
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2017
1Oxygen (Dioxygen)IBA
10/2014
1Glucose (Dextrose)FDA LinkGeneric
10/2014
1MelatoninIBA
08/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2014
1Cell Adhesion Molecule-1IBA
08/2013
1Phosphotransferases (Kinase)IBA
07/2013
1Nimodipine (Modus)FDA LinkGeneric
05/2000

Therapy/Procedure

2Craniotomy
02/2023 - 02/2018
2Therapeutics
11/2021 - 01/2018
2Personal Protective Equipment
10/2020 - 01/2020
2Neurosurgical Procedures
10/2020 - 01/2020
1Surgical Decompression
09/2023
1Decompression
09/2023
1Ligation
09/2023
1Bed Rest (Bedrest)
06/2022
1Laser Therapy (Surgery, Laser)
01/2018